---
title: "Tuoxin Pharmaceutical: Net loss of 18.2805 million yuan in the first half of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254621157.md"
description: "Tuoxin Pharmaceutical announced that its operating revenue in the first half of 2025 was 182 million yuan, a year-on-year decrease of 16.85%. The net loss was 18.2805 million yuan, compared to a loss of 1.7793 million yuan in the same period last year"
datetime: "2025-08-26T11:54:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254621157.md)
  - [en](https://longbridge.com/en/news/254621157.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254621157.md)
generator: "portal-rs"
---

# Tuoxin Pharmaceutical: Net loss of 18.2805 million yuan in the first half of 2025

Tuoxin Pharmaceutical announced that its operating revenue in the first half of 2025 was 182 million yuan, a year-on-year decrease of 16.85%. The net loss was 18.2805 million yuan, compared to a loss of 1.7793 million yuan in the same period last year

### Related Stocks

- [301089.CN](https://longbridge.com/en/quote/301089.CN.md)

## Related News & Research

- [EEOC moves to curb in-house enforcement of anti-bias laws against US agencies](https://longbridge.com/en/news/297088844.md)
- [Nimiq Opens Second Mini Apps Competition After Strong Debut](https://longbridge.com/en/news/297184111.md)
- [08:39 ETPredoc Launches Curated Data Layer to Make Fragmented Medical Records Usable](https://longbridge.com/en/news/297187951.md)
- [My Mountain Mover Recognized Among the 2026 Inc. 5000 Fastest-Growing U.S. Companies](https://longbridge.com/en/news/297087696.md)
- [Haisco Enters Into Exclusive License Agreement With New US Venture Founded By Population Health Partners And ARCH Venture Partners](https://longbridge.com/en/news/296910145.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**